Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Dalgleish

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|June 1, 1996
An alternative to 51Cr release assay for measurement of natural killer activity in HIV-infected patientsG P Rizzardi, L Brown, B E Souberbielle, et al.
Immunology|March 11, 2000
Heat shock proteins refine the danger theoryS M Todryk, A A Melcher, A G Dalgleish, et al.
Oncoimmunology|June 23, 2018
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cellsA M Gravett, N Trautwein, S Stevanović, et al.
Lancet (London, England)|August 26, 1998
Immune reconstitution in HAART-treated children with AIDS. Highly Active Anti-Retroviral TherapyM Sharland, A M Watkins, A G Dalgleish, et al.
Haematology and Blood Transfusion|January 1, 1987
Neutralization and receptor recognition of human T-lymphotropic retrovirusesR A Weiss, P R Clapham, A G Dalgleish, et al.
Science (New York, N.Y.)|November 28, 1986
Epitopes of the CD4 antigen and HIV infectionQ J Sattentau, A G Dalgleish, R A Weiss, et al.
AIDS Research and Human Retroviruses|January 11, 2000
Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activityM H Shearer, A G Dalgleish, T C Chanh, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 1, 1986
Is Crohn's disease caused by a lymphotropic virus?R R Dourmashkin, I Sanderson, J A Walker-Smith, et al.
Postgraduate Medical Journal|January 1, 1989
Thrombophlebitis migrans following co-trimoxazole therapyJ Verne-Pignatelli, G P Spickett, A G Dalgleish, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 15, 2020
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cellsP L Smith, Y Yogaratnam, M Samad, et al.
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|June 1, 1996
An alternative to 51Cr release assay for measurement of natural killer activity in HIV-infected patientsG P Rizzardi, L Brown, B E Souberbielle, et al.
Immunology|March 11, 2000
Heat shock proteins refine the danger theoryS M Todryk, A A Melcher, A G Dalgleish, et al.
Oncoimmunology|June 23, 2018
Gemcitabine alters the proteasome composition and immunopeptidome of tumour cellsA M Gravett, N Trautwein, S Stevanović, et al.
Lancet (London, England)|August 26, 1998
Immune reconstitution in HAART-treated children with AIDS. Highly Active Anti-Retroviral TherapyM Sharland, A M Watkins, A G Dalgleish, et al.
Haematology and Blood Transfusion|January 1, 1987
Neutralization and receptor recognition of human T-lymphotropic retrovirusesR A Weiss, P R Clapham, A G Dalgleish, et al.
Science (New York, N.Y.)|November 28, 1986
Epitopes of the CD4 antigen and HIV infectionQ J Sattentau, A G Dalgleish, R A Weiss, et al.
AIDS Research and Human Retroviruses|January 11, 2000
Idiotype cascades associated with the CD4-HIV glycoprotein 120 interaction: immunization with anti-idiotypic antibodies induces anti-anti-idiotypic responses with anti-CD4 specificity and in vitro neutralizing activityM H Shearer, A G Dalgleish, T C Chanh, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 1, 1986
Is Crohn's disease caused by a lymphotropic virus?R R Dourmashkin, I Sanderson, J A Walker-Smith, et al.
Postgraduate Medical Journal|January 1, 1989
Thrombophlebitis migrans following co-trimoxazole therapyJ Verne-Pignatelli, G P Spickett, A G Dalgleish, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 15, 2020
Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cellsP L Smith, Y Yogaratnam, M Samad, et al.
Pageof 23